New mechanisms by which physical exercise improves insulin resistance in the skeletal muscle;Novos mecanismos pelos quais o exercício físico melhora a resistência à insulina no músculo esquelético

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 4, 2009, Pages 399-408

  Pauli, José Rodrigo ^a,b   Cintra, Dennys Esper ^b   de Souza, Claudio Teodoro ^c   Ropelle, Eduardo Rochette ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Exercise; Inflammation; Insulin resistance; Skeletal muscle

Indexed keywords

EID: 69149095263     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302009000400003     Document Type: Article

References (60)

1. Smith AG, Muscat GE. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int J Biochem Cell Biol. 2005;37(10):2047-63.
2. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teras M, Haaparanta M, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. The J Clin Invest. 1992;89(6):1767-74.
3. James DE, Burleigh KM, Kraegen EW, Chisholm DJ. Effect of acute exercise and prolonged training on insulin response to intravenous glucose in vivo in rat. J Appl Physiol. 1983;55(6):1660-4.
4. Eriksson J, Tuominen J, Valle T, Sundberg S, Sovijarvi A, Lindholm H, et al. Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance? Horm Metab Res. 1998;30(1):37-41.
5. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes. 1999;48(5):1192-7.
6. Luciano E, Carneiro EM, Carvalho CR, Carvalheira JB, Peres SB, Reis MA, et al. Endurance training improves responsiveness to insulin and modulates insulin signal transduction through the phosphatidylinositol 3-kinase/Akt-1 pathway. Eur J Endocrinol. 2002;147(1):149-57
7. Knowler WC, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
8. Chauveau A, Kaufamann M. Expériences pour la determination du coefficient de l'activité nutritive et respiratoire des muscles en respos et en travail. C R Hebd Seances Acad Sci. 1887;104(1):1126-32.
9. Burn JH, Dale HH. On the location of action of insulin. J Physiol. 1924;59(6):164-92.
10. Bjorntorp P, De Jounge K, Sjostrom L, Sullivan L. The effect of physical training on insulin production in obesity. Metabolism. 1970;19(8):631-8.
11. Bjorntorp P, Fahlen M, Grimby G, Gustafson A, Holm J, Renstrom P, et al. Carbohydrate and lipid metabolism in middle-aged, physically well-trained men. Metabolism. 1972;21(11):1037-44.
12. Mondon CE, Dolkas CB, Reaven GM. Site of enhanced insulin sensitivity in exercise-trained rats at rest. Am J Physiol. 1980;239(3):E169-77.
13. Patti ME, Kahn CR. The insulin receptor: a critical link in glucose homeostasis and insulin action. J Basic Clin Physiol Pharmacol. 1998;9(2-4):89-109.
14. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest. 2000;106(2)165-9.
15. White MF. The IRS-signalling system: a network of docking proteins that mediate insulin action. Molecular Cell Biochemistry. 1998;182:3-11.
16. Backer JM, Myers MG Jr, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, et al. Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 1992;11(9):3469-79.
17. Czech MP, Corvera S. Signaling mechanisms that regulate glucose transport. J Biol Chem. 1999;274(4):1865-8.
18. Shephard PR, Nave BT, Siddle K. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem J. 1995;305(pt.1):25-8.
19. Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol. 1997;273(6):E1039-51.
20. Hardie DG, Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem. 1997;246(2):259-73.
21. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB. 1999;13(14):2051-60.
22. Wicklmayr M, Rett K, Fink E, Tschollar W, Dietze G, Mehnert H. Local liberation oh kinins by working skeletal muscle tissue in man. Hormone Metabolism Research. 1988;20(8):535.
23. Youn JH, Gulve EA, Holloszy JO. Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. Am J Cell Physiol. 1991;260(3 Pt 1):C555-61.
24. Holloszy JO, Hansen PA. Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol. 1996;128:99-103.
25. Roberts CK, Barnard RJ, Jasman A, Balon TW. Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J physiol Endocrinol Metab. 1999;277(2 Pt 1):E390-4.
26. Ropelle ER, Pauli JR, Prada PO, De Souza CT, Picardi PK, Cintra DE, et al. Reversal of diet-induced insulin resistance with single bout of exercise in the rat the role of PTP1B and IRS-1 serine phosphorylation. J Physiol. 2007;577:997-1007.
27. Pauli JR, Ropelle ER, Cintra DE, Carvalho-filho MA, Moraes, De Souza CT, et al. Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt in dietary induce obese Wistar rats. J Physiol. 2008;586:659-71.
28. Handschin C, Spiegelman BM. The role of exercise and PGC-1 in inflammation and chronic disease. Nature. 2008;454:463-9.
29. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science. 1996;271(5249):665-8.
30. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends immunology. 2004;25(1):4-7.
31. Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol Mech Dis. 2007;2:31-56.
32. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA. Loss-of-function mutation in toll-like receptor 4 prevents diet-induced and insulin resistance. Diabetes. 2007;56(8):1986-8.
33. Foster LJ, Klip A. Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. Am J Cell Physiol. 2000;279(4):C877-90.
34. Olson AL, Pessin JE. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr. 1996;16:235-56.
35. Knowler WC, Barret Connor E, Fowler SE. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
36. McPherson R, Jones PH. The metabolic syndrome and type 2 diabetes: role of the adipocyte. Curr Opin Lipidol. 2003;14(6):549-53.
37. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
38. Shulman GI. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology. 2004;19:183-90.
39. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87(2):507-20.
40. Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol. 2007;2:31-56.
41. Kim JK. Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab. 2006;4(6):417-9.
42. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009;29(2):359-70.
43. Shoelson SE, Lee J, Yuan M. Inflammation and the IKK beta/I kappa N/NF-kappa B axis in obesity- and diet-induced insulin resistance. J Clin Invest. 2003;106:171-6.
44. Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord. 2003;27:S53-55.
45. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JB, de Oliveira MG, et al. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes. 2005;54(4):959-67.
46. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol. 1995;57:737-69.
47. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, et al. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab. 2002;282:E386-94.
48. Carvalho-Filho MA, Ueno M, Carvalheira JB, Velloso LA, Saad MJ. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am J Physiol Endocrinol Metab. 2006;291(3):E476-82.
49. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98(4):1154-62.
50. Fischer CP, Berntsen A, Perstrup LB, Eskildsen P, Pedersen BK. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports. 2007;17(5):580-7.
51. Xie L, Lee SY, Andersen JN, Waters S, Shen K, Guo XL, et al. Cellular effects of small molecule PTP-1B inhibitors on insulin signaling. Biochemistry. 2003;42(44):3074-84.
52. Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes. 2003;52(1):21-8.
53. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283(5407):1544-8.
54. Sriwijitkamol A, Coletta DK, Wajcberg E, Balbontin GB, Reyna SM, Barrientes J, et al. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study. Diabetes. 2007;56(3):836-48.
55. Pilon G, Dallaire P, Marette A. Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J Biol Chem. 2004; 279(20): 20767-74.
56. Musi N, Fujii N, Hirshman MF, Ekberg I, Fröberg O, Ljungqvist O, et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes. 2001;50(5):921-7.
57. Pauli JR, Ropelle ER, Cintra DE, De Souza CT. Efeitos do exercício físico na expressão e atividade da AMPK em ratos obesos induzidos por dieta rica em gordura. Rev Bras Med Esporte. 2009;15(2):99-104.
58. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol. 1997;82(1):359-63.
59. Kapur S, Marcotte B, Marette A. Mechanism of adipose tissue iNOS induction in endotoxemia. Am J Physiol Endocrinol Metab. 1999;276(4 Pt 1):E635-41.
60. Bisquolo VA, Cardoso CG Jr, Ortega KC, Gusmao JL, Tinucci T, Negrao CE, et al. Previous exercise attenuates muscle sympathetic activity and increases blood flow during acute euglycemic hyperinsulinemia. J Appl Physiol. 2005;98(3):866-71.